Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,649 other S bills in the 118th — cohort avg 33d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2024 · fourth_quarter · Health Issues
HR 1692 / S 8, the Health Care Affordability Act; HR 2630 / S 652, the Safe Step Act; HR 3433 / S 2897, the Give Kids a Chance Act; HR 3503 / S 1701, The NIH Clinical Trial Diversity Act; HR 3991 / S 1624, the Gabriella Miller Kids First Act; HR 4363 / S 2213, Comprehensive Cancer Survivorship Act; HR 6003 / S 3103, the Medical Debt Relief Act; HR 6301 / S. 2039, The Cancer Drug Parity Act; HR 7383 / S 1214, the RARE Act; HR 8311 / S 4289, Medical Debt Cancellation Act; HR 824, the Telehealth Benefit Expansion for Workers Act; HR 1773, the Consumer Protection for Medical Debt Collections Act; HR 2813, Self-Insurance Protection Act; HR 2868, the Association Health Plans; HR 2880, the Protecting Patients Against PBM Abuses Act; HR 3799, CHOICE Arrangement Act; HR 3800, the Chronic Disease Flexible Coverage Act; HR 5609, the Advancing Health Savings Act; HR 5688, the Bipartisan HSA Improvement Act; HR 5687, the HSA Modernization Act; HR 6664, the Innovation in Pediatric Drugs Act; HR 6963, the Pediatric Cancer Drug Supply Chain Act; HR 7384, the Creating Hope Reauthorization Act; HR 8261, Preserving Telehealth, Hospital, and Ambulance Access Act; HR 8412, the Clinical Trial Modernization Act; HR 8574, the 340B ACCESS Act; HR 9129, Patient Debt Relief Act; S 113, the Prescription Pricing for the People Act; S 127, the Pharmacy Benefit Manager Transparency Act; S 1339, the Pharmacy Benefit Manager Reform Act; S 1542, the DRUG Act; S 1967 the Patients Before Middlemen Act; S 2243, the Palliative Care and Hospice Education and Training Act; S 2483, the Strengthening Consumer Protections and Medical Debt Transparency Act; S 2973, the Modernizing and Ensuring PBM Accountability Act; S 3167, Multiple Employer Welfare Arrangement (MEWA) Act; HR 9774 / S 5194, the Health Care Affordability Act; Legislation to protect insurance purchasers interacting with insurance brokers; Implementation of the No Surprises Act; Federal rulemaking related to Short-term Limited Duration Insurance (STLDI) plans; Efforts to extend and make permanent the current enhanced Advance Premium Tax Credits; Insurance appeals and denials; Federal rulemaking related to Association Health Plans; Consumer protections related to consumers who will lose insurance due to the end of certain federal Medicaid maintenance-of-effort requirements; FDA draft guidance related to dose optimization studies in clinical trials
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $180,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2024 · third_quarter · Health Issues
HR 1692 / S 8, the Health Care Affordability Act; HR 2630 / S 652, the Safe Step Act; HR 3433 / S 2897, the Give Kids a Chance Act; HR 3503 / S 1701, The NIH Clinical Trial Diversity Act; HR 3991 / S 1624, the Gabriella Miller Kids First Act; HR 4363 / S 2213, Comprehensive Cancer Survivorship Act; HR 6003 / S 3103, the Medical Debt Relief Act; HR 6301 / S. 2039, The Cancer Drug Parity Act; HR 7383 / S 1214, the RARE Act; HR 8311 / S 4289, Medical Debt Cancellation Act; HR 824, the Telehealth Benefit Expansion for Workers Act; HR 1773, the Consumer Protection for Medical Debt Collections Act; HR 2813, Self-Insurance Protection Act; HR 2868, the Association Health Plans; HR 2880, the Protecting Patients Against PBM Abuses Act; HR 3799, CHOICE Arrangement Act; HR 3800, the Chronic Disease Flexible Coverage Act; HR 5609, the Advancing Health Savings Act; HR 5688, the Bipartisan HSA Improvement Act; HR 5687, the HSA Modernization Act; HR 6664, the Innovation in Pediatric Drugs Act; HR 6963, the Pediatric Cancer Drug Supply Chain Act; HR 7384, the Creating Hope Reauthorization Act; HR 8261, Preserving Telehealth, Hospital, and Ambulance Access Act; HR 8412, the Clinical Trial Modernization Act; HR 8574, the 340B ACCESS Act; HR 9129, Patient Debt Relief Act; S 113, the Prescription Pricing for the People Act; S 127, the Pharmacy Benefit Manager Transparency Act; S 1339, the Pharmacy Benefit Manager Reform Act; S 1542, the DRUG Act; S 1967 the Patients Before Middlemen Act; S 2243, the Palliative Care and Hospice Education and Training Act; S 2483, the Strengthening Consumer Protections and Medical Debt Transparency Act; S 2973, the Modernizing and Ensuring PBM Accountability Act; S 3167, Multiple Employer Welfare Arrangement (MEWA) Act; HR 9774 / S 5194, the Health Care Affordability Act; Legislation to protect insurance purchasers interacting with insurance brokers; Implementation of the No Surprises Act; Federal rulemaking related to Short-term Limited Duration Insurance (STLDI) plans; Efforts to extend and make permanent the current enhanced Advance Premium Tax Credits; Insurance appeals and denials; Federal rulemaking related to Association Health Plans; Consumer protections related to consumers who will lose insurance due to the end of certain federal Medicaid maintenance-of-effort requirements; FDA draft guidance related to dose optimization studies in clinical trials
Client expense: $160,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Treasury, Dept of, White House Office
2024 · second_quarter · Health Issues
HR 1692 / S 8, the Health Care Affordability Act; HR 2630 / S 652, the Safe Step Act; HR 3433 / S 2897, the Give Kids a Chance Act; HR 3503 / S 1701, The NIH Clinical Trial Diversity Act; HR 3991 / S 1624, the Gabriella Miller Kids First Act; HR 4363 / S 2213, Comprehensive Cancer Survivorship Act; HR 6003 / S 3103, the Medical Debt Relief Act; HR 6301 / S. 2039, The Cancer Drug Parity Act; HR 7383 / S 1214, the RARE Act; HR 824, the Telehealth Benefit Expansion for Workers Act; HR 1773, the Consumer Protection for Medical Debt Collections Act; HR 2813, Self-Insurance Protection Act; HR 2868, the Association Health Plans; HR 2880, the Protecting Patients Against PBM Abuses Act; HR 3799, CHOICE Arrangement Act; HR 3800, the Chronic Disease Flexible Coverage Act; HR 5609, the Advancing Health Savings Act; HR 5688, the Bipartisan HSA Improvement Act; HR 5687, the HSA Modernization Act; HR 6664, the Innovation in Pediatric Drugs Act; HR 6963, the Pediatric Cancer Drug Supply Chain Act; HR 7384, the Creating Hope Reauthorization Act; S 113, the Prescription Pricing for the People Act; S 127, the Pharmacy Benefit Manager Transparency Act; S 1339, the Pharmacy Benefit Manager Reform Act; S 1542, the DRUG Act; S 1967 the Patients Before Middlemen Act; S 2243, the Palliative Care and Hospice Education and Training Act; S 2483, the Strengthening Consumer Protections and Medical Debt Transparency Act; S 2973, the Modernizing and Ensuring PBM Accountability Act; S 3167, Multiple Employer Welfare Arrangement (MEWA) Act; Legislation to protect insurance purchasers interacting with insurance brokers; Implementation of the No Surprises Act; Federal rulemaking related to Short-term Limited Duration Insurance (STLDI) plans; Insurance appeals and denials; Federal rulemaking related to Association Health Plans; Consumer protections related to consumers who will lose insurance due to the end of certain federal Medicaid maintenance-of-effort requirements; FDA draft guidance related to dose optimization studies in clinical trials
Client expense: $570,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
2024 · second_quarter · Small Business
House H.R. 572, the Ensuring Workers Get PAID Act - support. H.R. 1843, the Telehealth Expansion Act - support. H.R. 824, the Telehealth Benefit Expansion for Workers Act of 2023 - support. H.R. 2811, the Limit, Save, Grow Act of 2023 - support. H.R. 4721, the Main Street Tax Certainty Act - support. H.R. 3881, the Credit Card Competition Act - support. H.R. 3799, the CHOICE Arrangement Act - support. S.J.Res.11, CRA resolution of disapproval for the EPA final rule relating to increased emissions standards for new heavy duty trucks - support. H.R. 2868, the Association Health Plan Act - support. H.R. 2813, the Self-Insurance Protection Act - support. H.R. 4428, the Guidance Clarity Act - support. H.R. 890, the Guidance Out Of Darkness (GOOD) Act - support. H.R. 5378, the Lower Costs, More Transparency Act - support. Norcross amendment (submitted as #144) to the National Defense Authorization Act for 2024 - oppose. H.R. 3417, FAIR Act - support. H.R. 1163, the Protecting Taxpayers and Victims of Unemployment Fraud Act - support. H.R. 4035, the Protecting Small Business Information Act of 2023 - support. H.J.Res. 98, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the National Labor Relations Board relating to "Standard for Determining Joint Employer Status. - support. S.J. Res. 32, providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to Small Business Lending Under the Equal Credit Opportunity Act (Regulation B). - support. H.R. 6514, Holding Agencies Accountable Act - support. H.R. 906, the REPAIR Act - support. H.R. 7198, Prove It Act - support. H.R. 7035, the Death Tax Repeal Act - support. H.J.Res. 147, providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Occupational Safety and Health Administration relating to "Worker Walkaround Representative Designation Process - support. H.R. 358, the Small Business Regulatory Flexibility Improvements Act (SBRFIA) - support H.R. 8639, Warehouse Worker Protection Act - oppose. H. J. RES. 129, the Congressional Review Act (CRA) resolution to repeal the Departments of Labor, the Treasury, and Health and Human Services Short-Term, Limited Duration Insurance and Independent, Noncoordinated Excepted Benefits Coverage rule - support. H.R. 8147, Repealing Big Brother Overreach Act - support. H.J.Res.116, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of the Labor relating to "Employee or Independent Contractor Classification Under the Fair Labor Standards Act" - support Senate S. 1108, the Death Tax Repeal Act - support. S. 122, the Ensuring Workers Get PAID Act - support. S. 954, the Affordable Insulin NOW Act of 2023 - oppose. S. 1001, the Telehealth Expansion Act - support. H.J.Res. 27, the Congressional Review Act (CRA) resolution of disapproval for the Waters of the United States (WOTUS) final rule - support. S.J.Res. 8, the Congressional Review Act (CRA) resolution of disapproval for the Department of Labor (DOL) final rule relating to environmental, social, and governance (ESG) factors for investment decisions - support. S. 1706, the Main Street Tax Certainty Act - support. S. 1838, the Credit Card Competition Act - support. Nomination of Acting Secretary Julie Sus for Secretary of DOL - oppose. S. 1339, the Pharmacy Benefit Manager Reform Act - support. S. 567, the Richard L. Trumka Protecting the Right to Organize (PRO) Act of 2023 - oppose. S. 728, the Paycheck Fairness Act - oppose. S. 1664, the Healthy Families Act - oppose. Marshall amendment to H.R. 4366, the Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024 - support. S. 1869, Site-based Invoicing and Transparency Enhancement (SITE) Act - support. S. 3167, the Multiple Employer Welfare Arrangement Act (MEWA Act) - support. the Employer Reporting Improvement Act and the Paperwork Burden Reduction Act - support. S. 2033, the American Innovation and Choice Online Act - support. S. 3227, Paperwork Burden Reduction Act - support. S. 3673, Commonsense Reporting Act - support. S. 1411, Prove It Act of 2023 - support. S. 1108, Death Tax Repeal Act - support. H.J.Res. 98, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the National Labor Relations Board relating to "Standard for Determining Joint Employer Status. - support. Extending the $7.5 million debt cap under Subchapter V of the Chapter 11 Bankruptcy code - support. H.R. 1147, Whole Milk for Healthy Kids Act - support. S. 3204, the Employer Reporting Improvement Act - support. S. 3202, the Paperwork Burden Reduction Act - support. S.J. Res. 61, the Congressional Review Act (CRA) Joint Resolution of Disapproval to nullify the Federal Highway Administrations (FHWA) final rule imposing greenhouse gas (GHG) emissions performance measures on state departments of transportation and metropolitan planning organizations - support. S.J. Res. 58, the Congressional Review Act (CRA) resolution to repeal the Department of Energy (DOE) final rule on gas furnace efficiency standards - support. S. 4297, Repealing Big Brother Overreach Act - support. S.J. Res. 76, the Congressional Review Act (CRA) resolution to repeal the Departments of Labor, the Treasury, and Health and Human Services Short-Term, Limited Duration Insurance and Independent, Noncoordinated Excepted Benefits Coverage rule - support. S.J.Res.63, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to "Employee or Independent Contractor Classification Under the Fair Labor Standards Act" - support. S.4260, Warehouse Worker Protection Act - oppose. Nomination (PN1789) of Lauren McGarity McFerran, of the District of Columbia, to be a Member of the National Labor Relations Board for the term of five years expiring December 16, 2029 - oppose. Testimony NFIB Statement for the Record, House Committee on Small Business, hearing titled, Under the Microscope: Examining FinCENs Implementation of the Corporate Transparency Act. April 30, 2024 Other Healthcare reform Joint trade letter - request for abandonment or at least postponement of DOLs anticipated overtime regulations under the FLSA Joint trade letter - support of the pending proposal to amend the Federal Rules of Civil Procedure to require disclosure of third-party litigation funding (TPLF) investment arrangements in any civil action filed in federal court Restoration of R&D expensing (Section 174) - support. Regulatory Flexibility Act reform - support. Joint trade letter - Congressional Review Act resolution to repeal the U.S. Department of Labor final rule, Updating the Davis-Bacon and Related Acts Regulations - support. Joint trade letter - H.R. 4035, Small Business Information Act - support. Joint trade letter - Thirty-Two Hour Workweek Act - oppose. Nomination of Acting Secretary Julie Su for Secretary of Labor (DOL) - oppose. Paid leave - oppose. American Privacy Rights Act. ENABLERS Act - oppose.
Client expense: $1,261,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
HR 3991 / S 1624, the Gabriella Miller Kids First Act; HR 3503 / S 1701, The NIH Clinical Trial Diversity Act; HR 6301 / S. 2039, The Cancer Drug Parity Act; HR 824, the Telehealth Benefit Expansion for Workers Act; HR 2868, the Association Health Plans; HR 2813, Self-Insurance Protection Act; HR 3799, CHOICE Arrangement Act; HR 4363 / S 2213, Comprehensive Cancer Survivorship Act; HR 2630 / S 652, the Safe Step Act; HR 7383 / S 1214, the RARE Act; S 2243, the Palliative Care and Hospice Education and Training Act; S 3167, Multiple Employer Welfare Arrangement (MEWA) Act; HR 1692 / S 8, the Health Care Affordability Act; HR 3800, the Chronic Disease Flexible Coverage Act; HR 5688 the Bipartisan HSA Improvement Act; HR 5687, the HSA Modernization Act; HR 5609, the Advancing Health Savings Act; HR 1773, the Consumer Protection for Medical Debt Collections Act; S 2483, the Strengthening Consumer Protections and Medical Debt Transparency Act; HR 6003 / S 3103, the Medical Debt Relief Act; HR 7384, the Creating Hope Reauthorization Act; HR 6664, the Innovation in Pediatric Drugs Act; HR 6963, the Pediatric Cancer Drug Supply Chain Act; HR 3433 / S 2897, the Give Kids a Chance Act; S 127, the Pharmacy Benefit Manager Transparency Act; S 113, the Prescription Pricing for the People Act; HR 2880, the Protecting Patients Against PBM Abuses Act; S 1967 the Patients Before Middlemen Act; S 2973, the Modernizing and Ensuring PBM Accountability Act; S 1339, the Pharmacy Benefit Manager Reform Act; S 1542, the DRUG Act; Implementation of the FY23 omnibus, specifically provisions related to increasing access to clinical trials; Implementation of the No Surprises Act; Federal rulemaking related to Short-term Limited Duration Insurance (STLDI) plans; Insurance appeals and denials; Federal rulemaking related to Association Health Plans; Consumer protections related to consumers who will lose insurance due to the end of certain federal Medicaid maintenance-of-effort requirements; Legislation to increase federal investment in Consumer Assistance Programs; FDA draft guidance related to dose optimization studies in clinical trials
Client expense: $100,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
2024 · first_quarter · Small Business
LD 2 Q1 2024 House H.R. 1843, the Telehealth Expansion Act - support. H.R. 824, the Telehealth Benefit Expansion for Workers Act of 2023 - support. H.R. 4721, the Main Street Tax Certainty Act - support. H.R. 3881, the Credit Card Competition Act - support. H.R. 3799, the CHOICE Arrangement Act - support. S.J.Res.11, CRA resolution of disapproval for the EPA final rule relating to increased emissions standards for new heavy duty trucks - support. H.R. 2868, the Association Health Plan Act - support. H.R. 2813, the Self-Insurance Protection Act - support. H.R. 4428, the Guidance Clarity Act - support. H.R. 890, the Guidance Out Of Darkness (GOOD) Act - support. H.R. 5378, the Lower Costs, More Transparency Act - support. Norcross amendment (submitted as #144) to the National Defense Authorization Act for 2024 - oppose. H.R. 3417, FAIR Act - support. H.R. 1163, the Protecting Taxpayers and Victims of Unemployment Fraud Act - support. H.R. 4035, the Protecting Small Business Information Act of 2023 - support. H.J.Res. 98, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the National Labor Relations Board relating to "Standard for Determining Joint Employer Status. - support. S.J. Res. 32, providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to Small Business Lending Under the Equal Credit Opportunity Act (Regulation B). - support. H.R. 6514, Holding Agencies Accountable Act - support. H.R. 906, the REPAIR Act - support. H.R. 3493, ADA Improvement Act of 2023 - support. H.R. 7198, Prove It Act - support. H.R. 7035, the Death Tax Repeal Act - support. Corporate Transparency Act Repeal legislation Senate S. 1108, the Death Tax Repeal Act - support. S. 122, the Ensuring Workers Get PAID Act - support. S. 954, the Affordable Insulin NOW Act of 2023 - oppose. S. 1001, the Telehealth Expansion Act - support. H.J.Res. 27, the Congressional Review Act (CRA) resolution of disapproval for the Waters of the United States (WOTUS) final rule - support. S.J.Res. 8, the Congressional Review Act (CRA) resolution of disapproval for the Department of Labor (DOL) final rule relating to environmental, social, and governance (ESG) factors for investment decisions - support. S. 1706, the Main Street Tax Certainty Act - support. S. 1838, the Credit Card Competition Act - support. Nomination of Acting Secretary Julie Sus for Secretary of DOL - oppose. S. 1339, the Pharmacy Benefit Manager Reform Act - support. S. 567, the Richard L. Trumka Protecting the Right to Organize (PRO) Act of 2023 - oppose. S. 3167, the Multiple Employer Welfare Arrangement Act (MEWA Act) - support. the Employer Reporting Improvement Act and the Paperwork Burden Reduction Act - support. S. 2033, the American Innovation and Choice Online Act - support. S. 3227, Paperwork Burden Reduction Act - support. S. 3673, Commonsense Reporting Act - support. S. 1411, Prove It Act of 2023 - support. S. 1108, Death Tax Repeal Act - support. H.J.Res. 98, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the National Labor Relations Board relating to "Standard for Determining Joint Employer Status. - support. Extending the $7.5 million debt cap under Subchapter V of the Chapter 11 Bankruptcy code - support. H.R. 1147, Whole Milk for Healthy Kids Act - support. S. 3204, the Employer Reporting Improvement Act - support. S. 3202, the Paperwork Burden Reduction Act - support. S.J. Res. 61, the Congressional Review Act (CRA) Joint Resolution of Disapproval to nullify the Federal Highway Administrations (FHWA) final rule imposing greenhouse gas (GHG) emissions performance measures on state departments of transportation and metropolitan planning organizations - support. Corporate Transparency Act - repeal legislation. Testimony NFIB Statement for the Record, House Energy and Commerce Health Subcommittee, hearing titled, Health Care Spending In The United States: Unsustainable For Patients, Employers, And, Taxpayers, January 31, 2024. NFIB Statement for the Record, House Committee on Education and the Workforce, comments to the Committee on Education and the Workforce request for information on ways to build upon and strengthen ERISA (Employee Retirement Income Security Act of 1974) the foundation of employer-sponsored health care, March 15, 2024. NFIB Statement for the Record, House Committee on Financial Services, hearing titled, Oversight of the Financial Crimes Enforcement Network (FinCEN) and the Office of Terrorism and Financial Intelligence (TFI), February 14, 2024. Other Healthcare reform Joint trade letter - request for abandonment or at least postponement of DOLs anticipated overtime regulations under the FLSA Joint trade letter - support of the pending proposal to amend the Federal Rules of Civil Procedure to require disclosure of third-party litigation funding (TPLF) investment arrangements in any civil action filed in federal court Restoration of R&D expensing (Section 174) - support. Regulatory Flexibility Act reform - support. Beneficial ownership information reporting requirements - oppose. Joint trade letter - Congressional Review Act resolution to repeal the U.S. Department of Labor final rule, Updating the Davis-Bacon and Related Acts Regulations - support. ADA lawsuit abuse Joint trade letter - H.R. 4035, Small Business Information Act - support. Joint trade letter - Thirty-Two Hour Workweek Act - oppose. Nomination of Acting Secretary Julie Su for Secretary of Labor (DOL) - oppose. Paid leave - oppose.
2023 · fourth_quarter · Small Business
House H.R. 572, the Ensuring Workers Get PAID Act - support. H.R. 1843, the Telehealth Expansion Act - support. H.R. 824, the Telehealth Benefit Expansion for Workers Act of 2023 - support. H.R. 2811, the Limit, Save, Grow Act of 2023 - support. H.R. 4721, the Main Street Tax Certainty Act - support. H.R. 3881, the Credit Card Competition Act - support. H.R. 3799, the CHOICE Arrangement Act - support. S.J.Res.11, CRA resolution of disapproval for the EPA final rule relating to increased emissions standards for new heavy duty trucks - support. H.R. 2868, the Association Health Plan Act - support. H.R. 2813, the Self-Insurance Protection Act - support. H.R. 4428, the Guidance Clarity Act - support. H.R. 890, the Guidance Out Of Darkness (GOOD) Act - support. H.R. 5378, the Lower Costs, More Transparency Act - support. Norcross amendment (submitted as #144) to the National Defense Authorization Act for 2024 - oppose. H.R. 3417, FAIR Act - support. H.R. 1163, the Protecting Taxpayers and Victims of Unemployment Fraud Act - support. H.R. 4035, the Protecting Small Business Information Act of 2023 - support. H.J.Res. 98, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the National Labor Relations Board relating to "Standard for Determining Joint Employer Status. - support. S.J. Res. 32, providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to Small Business Lending Under the Equal Credit Opportunity Act (Regulation B). - support. H.R. 6514, Holding Agencies Accountable Act - support. H.R. 906, the REPAIR Act - support. H.R. 3493, ADA Improvement Act of 2023 - support. Senate S. 1108, the Death Tax Repeal Act - support. S. 122, the Ensuring Workers Get PAID Act - support. S. 954, the Affordable Insulin NOW Act of 2023 - oppose. S. 1001, the Telehealth Expansion Act - support. H.J.Res. 27, the Congressional Review Act (CRA) resolution of disapproval for the Waters of the United States (WOTUS) final rule - support. S.J.Res. 8, the Congressional Review Act (CRA) resolution of disapproval for the Department of Labor (DOL) final rule relating to environmental, social, and governance (ESG) factors for investment decisions - support. S. 1706, the Main Street Tax Certainty Act - support. S. 1838, the Credit Card Competition Act - support. Nomination of Acting Secretary Julie Sus for Secretary of DOL - oppose. S. 1339, the Pharmacy Benefit Manager Reform Act - support. S. 567, the Richard L. Trumka Protecting the Right to Organize (PRO) Act of 2023 - oppose. S. 728, the Paycheck Fairness Act - oppose. S. 1664, the Healthy Families Act - oppose. Marshall amendment to H.R. 4366, the Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024 - support. S. 1869, Site-based Invoicing and Transparency Enhancement (SITE) Act - support. S. 3167, the Multiple Employer Welfare Arrangement Act (MEWA Act) - support. the Employer Reporting Improvement Act and the Paperwork Burden Reduction Act - support. S. 2033, the American Innovation and Choice Online Act - support. S. 3227, Paperwork Burden Reduction Act - support. S. 3673, Commonsense Reporting Act - support. S. 1411, Prove It Act of 2023 - support. S. 1108, Death Tax Repeal Act - support. Testimony NFIB Elizabeth Milito testified before the United States Senate Committee on Finance, Exploring Paid Leave: Policy, Practice, and Impact on the Workforce. October 25, 2023 Other Healthcare reform Joint trade letter - request for abandonment or at least postponement of DOLs anticipated overtime regulations under the FLSA Joint trade letter - support of the pending proposal to amend the Federal Rules of Civil Procedure to require disclosure of third-party litigation funding (TPLF) investment arrangements in any civil action filed in federal court Restoration of R&D expensing (Section 174) - support. Regulatory Flexibility Act reform - support. Beneficial ownership information reporting requirements - oppose. Joint trade letter - Congressional Review Act resolution to repeal the U.S. Department of Labor final rule, Updating the Davis-Bacon and Related Acts Regulations - support. ADA lawsuit abuse Joint trade letter - H.R. 4035, Small Business Information Act - support.
Client expense: $1,296,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Client expense: $1,120,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE